EFFICACY AND SAFETY OF BUDESONIDE AS FIRST LINE TREATMENT IN PATIENTS WITH AUTOIMMUNE HEPATITIS: SPANISH MULTICENTER STUDY

被引：0

作者：

Diaz-Gonzalez, Alvaro ^{[1
,2
]}

Hernandez-Guerra, Manuel ^{[3
]}

Gomez, Elena ^{[4
]}

Sapena, Victor ^{[5
]}

Perez-Medrano, Indhira ^{[6
]}

Del Barrio, Maria ^{[7
]}

Escude, Laia ^{[8
]}

Riveiro Barciela, Mar ^{[9
]}

Barreira-Diaz, Ana ^{[9
]}

Soria, Anna ^{[10
]}

Molina, Esther ^{[11
]}

Ferre-Aracil, Carlos ^{[12
]}

El Hajra, Ismael ^{[12
]}

Arencibia, Ana C. ^{[13
]}

Morillas Cunill, Rosa M. ^{[14
]}

Gomez-Camarero, Judith ^{[15
]}

Conde, Isabel ^{[16
]}

Mateos, Beatriz ^{[17
]}

Horta, Diana ^{[18
]}

Estevez, Pamela ^{[19
]}

Lopez, Carmen ^{[20
]}

Navascues, Carmen A. ^{[21
]}

Zamora, Javier ^{[22
]}

Garcia-Retortillo, Montserrat ^{[23
]}

Fernandez, Ainhoa ^{[24
]}

Crespo Garcia, Javier ^{[25
]}

Carlota Londono, Maria ^{[26
]}

机构：

[1] Hosp Univ Marques De Valdecilla, Digest Dis Dept, Inst Invest Sanitaria Valdecilla, Santander, Spain

[2] Hosp Univ Marques De Valdecilla, Santander, Spain

[3] Univ Hosp Canary Isl, Dept Gastroenterol, San Cristobal Laguna, Spain

[4] Hosp Univ 12 Octubre, Digest Dis Dept, Madrid, Spain

[5] Hosp Clin Barcelona, IDIBAPS, Med Stat Core Facil, Barcelona, Spain

[6] Complejo Hosp Univ Pontevedra, Digest Dis Dept, Pontevedra, Spain

[7] Marques De Valdecilla Univ Hosp, Gastroenterol & Hepatol, Santander, Spain

[8] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

[9] Hosp Univ Vall Dhebron, Dept Internal Med, Liver Unit, Barcelona, Spain

[10] Univ Autonoma Barcelona, Parc Tauli Hosp Univ, I3PT, Liver Unit, Sabadell, Spain

[11] Complejo Hosp Univ Santiago, Digest Dis Dept, Santiago De Compostela, Spain

[12] Hosp Univ Puerta De Hierro Majadahonda, Digest Dis Dept, Madrid, Spain

[13] Hosp Univ Nuestra Senora Candelaria, Liver Unit, Santa Cruz De Tenerife, Spain

[14] Hosp Badalona Germans Trias & Pujol, Hepatol Unit, Barcelona, Spain

[15] Hosp Univ Burgos, Burgos, Spain

[16] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Digest Dis Dept, Valencia, Spain

[17] HU Ramon y Cajal, Gastroenterol, Madrid, Spain

[18] Hosp Univ Mutua Terrassa, Digest Dis Dept, Terrassa, Spain

[19] Hosp Univ Alvaro Cunqueiro, Digest Dis Dept, Vigo, Spain

[20] Hosp Univ Josep Trueta, Digest Dis Dept, Girona, Spain

[21] Hosp Univ Cent Asturias, Liver Unit, Div Gastroenterol & Hepatol, Oviedo, Spain

[22] Hosp Univ Reina Sofia, Digest Dis Dept, Cordoba, Spain

[23] Hosp Del Mar, Serv Digest, Secc Hepatol, Barcelona, Spain

[24] Hosp Gen Univ Gregorio Maranon, Digest Dis Dept, Madrid, Spain

[25] Hosp Univ Marques De Valdecilla, Digest Dis Dept, Inst Invest Sanitaria Valdecilla, Santander, Spain

[26] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

来源：

HEPATOLOGY | 2021年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1268

引用

页码：761A / 762A

页数：2

共 50 条

[21] Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome
Efe, Cumali
Ozaslan, Ersan
Kav, Taylan
Purnak, Tugrul
Shorbagi, Ali
Ozkayar, Ozgur
Berlot, Alexandra Heurgue
Sokmensuer, Cenk
Muratori, Paolo
AUTOIMMUNITY REVIEWS, 2012, 11 (05) : 330 - 334
[22] Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
Efe, Cumali
Hagstrom, Hannes
Ytting, Henriette
Bhanji, Rahima A.
Muller, Niklas F.
Wang, Qixia
Purnak, Tugrul
Muratori, Luigi
Werner, Marten
Marschall, Hanns-Ulrich
Muratori, Paolo
Gunsar, Fulya
Klintman, Daniel
Pares, Albert
Heurgue-Berlot, Alexandra
Schiano, Thomas D.
Cengiz, Mustafa
Tana, Michele May-Sien
Ma, Xiong
Montano-Loza, Aldo J.
Berg, Thomas
Verma, Sumita
Larsen, Fin Stolze
Ozaslan, Ersan
Heneghan, Michael A.
Yoshida, Eric M.
Wahlin, Staffan
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (12) : 1950 - +
[23] The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients A Multicenter Real-Life Study
Akdeniz, Nadiye
Kaplan, Muhammet Ali
Inanc, Mevlude
Uncu, Dogan
Ergun, Yakup
Kucukoner, Mehmet
Demirci, Ayse
Sendur, Mehmet Ali Nahit
Besiroglu, Mehmet
Topcu, Atakan
Yerlikaya, Halis
Urakci, Zuhat
Kilickap, Saadettin
Isikdogan, Abdurrahman
PANCREAS, 2022, 51 (09) : 1153 - 1159
[24] Efficacy of Oral Budesonide in Combination with Low Dose Azathioprine in Induction of Remission for Patients with Autoimmune Hepatitis. a Retrospective Multicenter Experience.
Ismail, Bahaaeldeen
Rodriguez, Sandra
Liang, Yin
Sojo, Paul
Benrajab, Karim
Rosenau, Jens
Castro-Pavia, Fernando J.
HEPATOLOGY, 2018, 68 : 1124A - 1124A
[25] ORAL BUDESONIDE FOR TREATMENT OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
DANIELSSON, A
PRYTZ, H
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1994, 8 (06) : 585 - 590
[26] Multicenter study on the discontinuation and efficacy of chronic hepatitis C treatment in the Spanish penitentiary population (EPIBAND study)
de Juan, Jose
Saiz de la Hoya, Pablo
Marco, Andres
Anton, Jose J.
Faraco, Inmaculada
Yllobre, Carlos
Pozo, Edelmira
Hoyos, Carmen
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (10) : 1083 - 1089
[27] Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis
Mohammad, Saeed
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (06) : 753 - 762
[28] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
Taubert R.
Engel B.
Die Innere Medizin, 2024, 65 (4) : 325 - 333
[29] Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study
Lu Jin
Chen Wen-Ming
Geng Chuan-Ying
Durie Brian GM
Huang Xiao-Jun
中华医学杂志英文版, 2016, 129 (03) : 274 - 278
[30] Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study
Lu, Jin
Chen, Wen-Ming
Geng, Chuan-Ying
Durie, Brian G. M.
Huang, Xiao-Jun
CHINESE MEDICAL JOURNAL, 2016, 129 (03) : 274 - 278

← 1 2 3 4 5 →